Daroxime 500mg

Quick links

Choose a section

Quick links to important sections

Advertisements

Daroxime 500mg

Advertisements
Advertisements

Treatment option:

Advertisements

Overview of Daroxime 500mg

Quick Facts

Property Description
Active Ingredient Cefuroxime axetil
Form Oral tablet (or capsule)
Pharmacological Class Cephalosporin (Second Generation)
General Purpose Treating susceptible bacterial infections
Origin Semisynthetic

Daroxime 500mg: An Overview of Its Type and Class

Daroxime 500mg is a prescription antibacterial medication that belongs to the cephalosporin family of antibiotics, recognized globally for their broad-spectrum effectiveness. The drug is synthetic in origin, meaning it is manufactured for its specific therapeutic purpose of fighting bacteria. It is specifically categorized as a second-generation cephalosporin, a class characterized by enhanced stability against certain bacterial enzymes compared to the earlier generation of these drugs.

As an antibiotic, Daroxime is solely intended to eliminate or control bacteria. Its use involves handling a variety of infections where prompt action against susceptible bacteria is necessary, such as in the case of common respiratory tract infections. This confirms that the medication is designed to treat only specific types of microbial infection and is not effective against viral or fungal diseases.


Composition, Form, and General Purpose

The active ingredient in Daroxime 500mg is Cefuroxime axetil, a prodrug that is rapidly converted to the potent Cefuroxime compound inside the body. The "500mg" refers to the precise strength of Cefuroxime contained in the dosage unit, which is typically formulated as an oral tablet for ease of patient administration.

Cefuroxime is distinguished by its bactericidal action, which involves direct interference with the synthesis of the bacterial cell wall. This mechanism prevents the bacteria from building their necessary protective structure. The general purpose of administering Daroxime 500mg is to deliver a consistent dose of this cell wall-inhibiting agent to rapidly reduce the bacterial population, a key step in promoting swift resolution of the infection.

Regulatory References

  1. second-generation cephalosporin
  2. Cefuroxime: MedlinePlus Drug Information
  3. CEFUROXIME AXETIL tablet, film coated - DailyMed
  4. Cefuroxime - StatPearls - NCBI Bookshelf
Advertisements

What side effects are possible with Daroxime 500mg?

Possible Side Effects and Safety Information

This section outlines the officially documented adverse reactions and safety statements for Daroxime 500mg (Cefuroxime Axetil) as defined by regulatory authorities.

Frequency-Classified Adverse Reactions

Adverse events are categorized by frequency based on clinical trial and post-marketing data:

Frequency Examples of Documented Reactions
Common (ge 1/100 to < 1/10) Diarrhoea, nausea, headache, dizziness, abdominal pain, eosinophilia, transient increases in hepatic enzyme levels, Candida overgrowth (candidiasis).
Uncommon (ge 1/1,000 to < 1/100) Vomiting, skin rashes, leukopenia, thrombocytopenia, positive Coombs' test.
Frequency Not Known Pseudomembranous colitis, seizures, encephalopathy, acute renal failure, hepatitis, jaundice (predominantly cholestatic).

Serious Adverse Reactions and Restrictions

Serious Adverse Reactions (SARs) officially documented include Anaphylaxis and other severe hypersensitivity reactions, Severe Cutaneous Adverse Reactions (SCARs) such as Stevens-Johnson Syndrome (SJS), and Pseudomembranous Colitis (due to C. difficile overgrowth). These reactions, while rare, are clinically significant.

Contraindication: Daroxime 500mg is strictly contraindicated in patients with a known hypersensitivity to the drug, any other cephalosporin, or a history of severe immediate hypersensitivity to any beta-lactam antibacterial drug.

Population-Specific Safety Notes

Renal Impairment: Dosage adjustment is required for patients with severe renal impairment to prevent elevated plasma concentrations, which may increase the risk of CNS toxicity (e.g., seizures). Pregnancy and Lactation: Use should only occur if the potential benefit justifies the risk, and it is known to be excreted in small quantities in breast milk.

Interference with Tests: The medication may cause a false-positive result in copper reduction tests for urine glucose and may induce a positive direct Coombs' Test.

Advertisements

Overdose and Emergency Response

Overdose and When to Seek Help: Official Regulatory Information

The following information details the officially documented manifestations and required emergency actions in the event of an overdose with Daroxime 500mg (Cefuroxime axetil), as defined by government regulatory authorities.

Documented Overdose Manifestations

Official labeling indicates that overdosage of this class of antibiotic can lead to cerebral irritation. This may result in specific neurological symptoms, which are documented to include convulsions and encephalopathy. In severe cases, these neurological effects are noted to potentially lead to coma.

Required Emergency Actions

Action Area Official Regulatory Statement
Seeking Urgent Help Contact a healthcare professional, hospital emergency department, or regional Poison Control center immediately if an overdose is suspected.
Antidote There is no specific antidote listed in the official prescribing information.
Management Treatment is required to be symptomatic and supportive. The active drug, Cefuroxime, is noted as being removable by haemodialysis and peritoneal dialysis.

Population-Specific Overdose Note

Official documents specifically address a higher risk for overdose symptoms in patients with renal impairment (kidney dysfunction). The neurological sequelae of overdose may occur if the dose is not appropriately reduced for individuals with impaired kidney function.

Advertisements

Therapeutic Uses of Daroxime 500mg

What Daroxime 500mg Treats: Main Uses and Benefits

Daroxime 500mg (Cefuroxime axetil) is a medication commonly used to help with acute, community-acquired conditions presenting with systemic or localized discomfort caused by susceptible bacteria. Its therapeutic focus is on managing symptoms associated with acute or disruptive episodes, which helps to ease the overall symptom burden and supports patient comfort.

This therapeutic domain encompasses several common illnesses, including conditions of the upper and lower respiratory tract, uncomplicated urinary tract infections (UTIs), skin and soft tissue infections, and the initial stages of early Lyme disease.

Quick Fact: Relief for Respiratory Symptoms The medication contributes to improved comfort during periods of heightened symptoms associated with bacterial bronchitis and sinusitis, and supports the patient during difficult episodes by easing distress.


The medication is frequently applied in clinical settings that involve acute or unstable symptom patterns marked by heightened discomfort. It is used for managing symptom clusters that may become intense or disruptive, such as those related to systemic imbalance, local physical discomfort, and irritative states. This assists with maintaining functional stability and supports general well-being during symptomatic phases.

Regulatory References

  1. NIH DailyMed Prescribing Information
Advertisements

Eligibility and Restrictions for Use

Eligibility Map: Who Can and Cannot Use Daroxime 500mg (Cefuroxime Axetil)

The population eligibility for Daroxime 500mg is strictly defined by regulatory documents, focusing on hypersensitivity status, age, organ function, and reproductive status.


Contraindicated Populations

Classification Population
Absolute Contraindication Patients with known hypersensitivity to Cefuroxime or to any antibiotic in the cephalosporin class.
Absolute Contraindication Patients with a history of severe allergic reactions (e.g., anaphylaxis) to any other beta-lactam antibacterial agent, including penicillins.

Age- and Condition-Based Restrictions

Population Group Eligibility Status
Adults and Adolescents Approved for use in patients aged 13 years and older.
Infants (Under 3 Months) Safety and effectiveness have not been established.
Renal Impairment Conditional Use: Requires a dosage reduction in patients with markedly impaired renal function.
Pregnancy and Lactation Conditional Use: Use is restricted to cases where the clinical benefit clearly outweighs the potential risk.

Note: While adult and geriatric populations are generally approved, individuals with a history of colitis or gastrointestinal malabsorption are designated for conditional use only.

Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory information for Daroxime 500mg (Cefuroxime axetil) outlines specific interactions that can affect the drug's exposure or potentiate certain effects. The primary areas of concern relate to changes in absorption and elimination.

Pharmacokinetic and Exposure Interactions

Interacting Product Category Effect on Daroxime Exposure Regulatory Caution
Drugs that reduce gastric acidity (e.g., antacids, H2-receptor antagonists, PPIs) Decreased bioavailability (absorption) of Daroxime. May require monitoring.
Probenecid (Uricosuric Agent) Significantly increased systemic exposure of Daroxime. Co-administration is not recommended due to competition for renal tubular secretion.

Pharmacodynamic and Clinical Effect Interactions

Co-administration with other medicines may lead to altered clinical effects, as documented by official regulatory sources:

  • Oral Contraceptives: The use of Daroxime may potentially reduce the efficacy of oral contraceptives due to effects on gut flora, which can impact estrogen reabsorption. Patients should be advised of this potential risk.
  • Anticoagulants: When Daroxime is combined with oral anticoagulants, there is a documented potential for an increase in the International Normalized Ratio (INR) or prothrombin time.
  • Nephrotoxic Agents: Concurrent use with medicines known to be nephrotoxic may be associated with an increased risk of nephrotoxicity.
Advertisements

Mechanism of Action

Cefuroxime acts primarily within the domain of bacterial cell wall biosynthesis. As a beta-lactam compound, the molecule covalently binds to and inactivates specific bacterial enzymes known as penicillin-binding proteins (PBPs).

Inhibition of Peptidoglycan Synthesis

PBPs are transpeptidases essential for catalyzing the cross-linking reactions of peptidoglycan, the structural polymer of the bacterial cell wall. By inhibiting the transpeptidation process, cefuroxime prevents the completion of the cell wall's final stage of assembly. This molecular-level interaction serves to modify early enzymatic steps that are critical for microbial structural integrity.

Disruption of Osmotic Stability

The synthesis of a structurally defective and weakened cell wall is the key downstream cascade of this inhibition. This physiological consequence leads to a significant disruption of the osmotic balance within the bacterial cell. This process culminates in a rapid influx of water, causing the bacterial cell to swell and ultimately resulting in lysis.

Advertisements

Dosage and Administration Information

Daroxime 500mg (Cefuroxime axetil) is a medication that is administered exclusively via the oral route. It is available in 500 mg film-coated tablets and as an oral suspension, but the two formulations are not interchangeable on a milligram-for-milligram basis.

Standard Dosing and Administration

The standard regimen for Daroxime is twice daily (every 12 hours) for a defined period, typically ranging from 7 to 10 days for most conditions, though treatment for early Lyme disease may be extended to 20 days. The required adult dose generally falls between 250 mg and 500 mg per dose, with 1000 mg as a single dose for a specific indication.

Administration Rule Guideline
Tablet Intake Condition May be taken with or without food. Administration after food is often utilized for optimum absorption.
Suspension Intake Condition Must be taken with food to maximize absorption.
Handling Restriction The film-coated tablets must be swallowed whole and are not to be crushed, broken, or chewed.

Population-Specific Adjustment

Dosage adjustment is necessary for patients with significantly impaired renal function. For individuals with a creatinine clearance below 30 mL/min, the dosage and/or frequency must be modified to compensate for slower excretion.

Advertisements

Recent Clinical Evidence

Research Evidence / Overview of Studies for Daroxime 500mg

Overview of Studies for Respiratory and Throat Infections

Research on Daroxime 500mg (Cefuroxime axetil) has explored its use in several common conditions characterized by fluctuating or episodic manifestations of the respiratory tract, including acute bacterial sinusitis, acute exacerbations of chronic bronchitis (AECB), tonsillitis, and pharyngitis. For these indications, the evidence primarily comes from short-term Randomized Controlled Trials (RCTs) and comparative studies, which were designed to explore the drug's performance against other treatment options, including comparator agents or non-treatment groups (placebo).

In these studies, researchers monitored various outcomes, including how symptoms evolved in the observed populations, such as fever and local physical discomfort, alongside laboratory tests for bacteriological eradication. For tonsillitis and pharyngitis, research highlights changes measured during the study period related to monitoring for the presence or absence of the specific bacteria (S. pyogenes). The scope of comparative evidence is limited for highly resistant strains, and follow-up was typically short-term.


Studies on Urinary Tract and Skin Infections

Research has also examined Daroxime 500mg in the context of treating uncomplicated urinary tract infections (UTIs) and uncomplicated skin and soft tissue infections (SSTIs). For UTIs, comparative and open-label trials were used, and studies monitored key outcomes related to physical discomfort and systemic or functional imbalance, such as the timing of reported symptom change and indicators of bacteriological status. Studies reported measurements of clinical resolution and bacteriological clearance observed at follow-up periods ranging from one to several weeks.

Research Structure for Specific Bacterial Conditions

For Acute Otitis Media (AOM), comparative trials primarily examined measurements related to physical discomfort and overall clinical status in pediatric populations (from 3 months to 12 years old). For early Lyme disease, research relies on RCTs and systematic reviews. These studies monitored changes in the presentation of the rash and monitored long-term effects following the study period. What remains uncertain is the long-term data for AOM, as some trials were terminated early, restricting statistical conclusions.


Understanding Long-Term Outcomes and Follow-Up

This section highlights that long-term effects are not fully established across most indications. While researchers often monitored patients for several weeks, there is limited information available from large-scale studies that track the durability of the response. Evidence for the long-term monitoring of infection status many months after treatment is an area where certainty remains low.


What is Still Uncertain About Daroxime 500mg Studies

Overall, the evidence quality varies across studies and indications. The data for certain groups remain insufficient, particularly for patients with complex existing health conditions or highly drug-resistant infections. Findings describe group patterns observed in the research and do not predict personal outcomes.

Key Studies & References

  1. CEFUROXIME AXETIL tablet - DailyMed - NIH (Official Prescribing Information)
  2. Management of acute otitis media in children six months of age and older (Clinical Guideline)
Advertisements

Frequently Asked Questions (FAQ)

Common questions about Daroxime 500mg (FAQ)


Q: How long does it usually take to notice an effect after starting Daroxime 500mg?

Official research studies track outcomes like symptom resolution over the entire course of treatment. For example, for conditions like early Lyme disease, clinical response is tracked at specific follow-up times after the full regimen. This indicates the medication is designed to achieve a reduction in symptoms that is monitored across the entire treatment period in studies.


Q: Is there a known issue with taking Daroxime 500mg with common vitamins or supplements?

Official drug product information focuses on established drug-drug interactions. The information generally does not establish specific interactions with common vitamins, supplements, or herbal products.


Q: Can Daroxime 500mg cause problems with sleep, such as insomnia or drowsiness?

Official clinical data indicates that the drug can be associated with central nervous system effects, including dizziness and headache, which are listed as common side effects. Sleepiness (somnolence) has also been reported in clinical trial data.


Q: Are there any specific foods or drinks described in official documents that interact with Daroxime 500mg?

Regulatory documents advise on whether to take the medication with or without food for absorption purposes. However, specific clinical interactions with particular foods or drinks have not been established in the official product information.


Q: Is it normal to feel a specific sensation or side effect when first starting Daroxime 500mg?

Common adverse reactions, such as diarrhea, nausea, headache, and dizziness, are reported in official safety documents. These types of side effects may occur early in the course of therapy.


Q: How does the body generally process Daroxime 500mg?

According to pharmacokinetics data, Daroxime 500mg acts as a prodrug, meaning it is rapidly converted into the active compound, Cefuroxime, after it is absorbed. This active drug is then primarily eliminated from the body largely unchanged through the urine.


Q: Can Daroxime 500mg be used by people who have existing heart conditions?

Non-clinical studies (conducted in animals) showed no acute effects on key heart measurements. Specifically, these studies showed no immediate effects on blood pressure, heart rate, or the electrocardiogram (ECG).


Q: What is the general duration of effect described for Daroxime 500mg after a single administration?

The elimination half-life of the active drug is described in pharmacokinetic data. In healthy adults, the mean elimination half-life (the time it takes for half the drug to be cleared from the body) is approximately 1.2 to 1.3 hours.


Q: Are there any specific warnings about driving or operating machinery while using Daroxime 500mg?

Official product information contains a specific caution regarding activities that require alertness. Because the medication may cause dizziness, individuals may need to exercise caution when engaging in activities such as driving or operating machinery.


Q: What is the purpose of the 500mg strength for this medicine?

The 500 mg tablet is one of the available strengths for oral administration used in the adult population. It is employed in various treatment regimens for susceptible infections, including certain courses for conditions like early Lyme disease.


Q: Does the time of day matter when taking Daroxime 500mg?

The standard course of treatment is administered twice daily, based on a defined period. This regimen aims to ensure a necessary concentration of the drug is maintained in the body throughout the treatment period.


Q: Are there any restrictions on activity or lifestyle while taking Daroxime 500mg?

Based on the potential for side effects that affect the central nervous system, such as dizziness, official information advises caution. This caution pertains to activities that require a high degree of alertness, such as driving or operating heavy equipment.


Q: What happens if a person misses a planned administration of Daroxime 500mg?

Official guidance usually indicates that if a dose is missed, the patient information advises to skip that dose and take the next dose at the regularly scheduled time, rather than taking two doses together.


Q: Are there any reported interactions between Daroxime 500mg and common over-the-counter pain relievers?

Official interaction documents warn about combining the drug with nephrotoxic agents, which are medicines known to potentially harm the kidneys. Due to the potential for increased risk of nephrotoxicity (kidney toxicity), caution is advised when combining with medicines that are known to be nephrotoxic, a category that includes some common pain relievers.


Q: Can Daroxime 500mg be used in elderly patients, and are there special considerations?

Dosage adjustment based on age alone is not typically necessary for older patients. However, Cefuroxime is eliminated by the kidneys, and the elimination half-life is known to be prolonged in geriatric patients with reduced renal function. Dose adjustment is generally recommended for patients with reduced renal function.


Q: Does Daroxime 500mg have any known impact on mood or mental clarity?

Official safety reports document central nervous system (CNS) effects, including headache and dizziness. More serious, though rare, post-marketing reports have included seizures and encephalopathy (brain disorder).


Q: What are the general expectations about discontinuing Daroxime 500mg?

The general recommendation found in patient information is to complete the full amount of medication as prescribed, even if symptoms begin to improve quickly. Stopping treatment early should only occur when specifically directed by a healthcare provider.


Q: Are there any specific warnings about combining Daroxime 500mg with alcohol?

While specific warnings may not be present in all general regulatory documents, case reports have documented a disulfiram-like reaction when Cefuroxime is combined with alcohol. This reaction is a documented adverse effect.


Q: Is it true that Daroxime 500mg can cause changes in weight?

Changes in weight are not listed in official documents as a common or uncommon side effect. However, according to post-marketing data, weight loss has been reported, although the exact incidence rate is not known.


Q: What are the general expectations regarding when Daroxime 500mg might be stopped by a healthcare provider?

The length of the treatment course is generally defined as 7 to 10 days for most conditions. However, treatment may be stopped earlier than the typical duration if a severe adverse reaction occurs, such as a serious hypersensitivity reaction.


Q: What is the significance of the tablet coating or delivery method for Daroxime 500mg?

The instructions state that the film-coated tablets should be swallowed whole and are not intended to be crushed, broken, or chewed. This is because the crushed tablet has a persistent and strong bitter taste.


Q: Does Daroxime 500mg affect blood pressure or heart rhythm?

Non-clinical studies (conducted in animals) did not show any acute effects on key cardiac metrics. Specifically, the drug was not found to acutely affect blood pressure, heart rate, or the readings of an electrocardiogram (ECG).


Q: Can the effectiveness of Daroxime 500mg be influenced by other existing health conditions?

Official documents note that caution is advised for patients with a history of gastrointestinal disease, particularly colitis, and for those with existing kidney disease.

Advertisements

How should Daroxime 500mg be stored and disposed of?

How to Store and Dispose of Daroxime 500mg

Storage Conditions

Daroxime 500mg (Cefuroxime axetil) tablets must be stored at Controlled Room Temperature, which is officially maintained between 20 C to 25 C (68 F to 77 F). The medication must be protected from excess heat and moisture and must not be exposed to freezing temperatures. Keep the tablets in the original container, tightly closed, to preserve stability and protect from the environment. Always store the medicine out of the reach and sight of children.

Disposal Instructions

Unused or expired Daroxime must be discarded according to local regulations. If a drug take-back program is unavailable, follow official guidelines: remove the tablets from the container, mix them with an undesirable substance (such as dirt), and place the mixture in a sealed bag or container before disposal in the household trash. Do not flush this medication down a sink or toilet.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Daroxime 500mg found in:

A-Z Index: